secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2026-05-14T21:02:35+00:00
Accession:  0001493152-26-023168
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology terminates ATM equity offering agreement after raising ~$5.68M
--------------------------------------------------------------------------------

- Suspended sales and gave notice to terminate At The Market Offering Agreement with H.C. Wainwright, effective 7 business days after May 14, 2026.
- Since March 28, 2025 prospectus supplement for $11.2M, sold 3,116,012 shares for gross proceeds of approx. $5,680,924.
- No further sales under the ATM facility; termination will be effective upon expiration of the notice period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000149315226023168/0001493152-26-023168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000149315226023168/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-023168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer